PHASE 2 TRIAL OF WEEKLY PACLITAXEL WITH PEMBROLIZUMAB IN PLATINUM RESISTANT RECURRENT OVARIAN CANCER
Conferences
Wenham, RM; McGuire, W; Fridley, B; Boulware, D; Apte, S; Chon, H; Shahzad, M; Secord, A
Published in: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
September 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
EISSN
1525-1438
ISSN
1048-891X
Publication Date
September 2018
Volume
28
Start / End Page
20 / 20
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wenham, R. M., McGuire, W., Fridley, B., Boulware, D., Apte, S., Chon, H., … Secord, A. (2018). PHASE 2 TRIAL OF WEEKLY PACLITAXEL WITH PEMBROLIZUMAB IN PLATINUM RESISTANT RECURRENT OVARIAN CANCER. In INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (Vol. 28, pp. 20–20).
Wenham, R. M., W. McGuire, B. Fridley, D. Boulware, S. Apte, H. Chon, M. Shahzad, and A. Secord. “PHASE 2 TRIAL OF WEEKLY PACLITAXEL WITH PEMBROLIZUMAB IN PLATINUM RESISTANT RECURRENT OVARIAN CANCER.” In INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 28:20–20, 2018.
Wenham RM, McGuire W, Fridley B, Boulware D, Apte S, Chon H, et al. PHASE 2 TRIAL OF WEEKLY PACLITAXEL WITH PEMBROLIZUMAB IN PLATINUM RESISTANT RECURRENT OVARIAN CANCER. In: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2018. p. 20–20.
Wenham, R. M., et al. “PHASE 2 TRIAL OF WEEKLY PACLITAXEL WITH PEMBROLIZUMAB IN PLATINUM RESISTANT RECURRENT OVARIAN CANCER.” INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol. 28, 2018, pp. 20–20.
Wenham RM, McGuire W, Fridley B, Boulware D, Apte S, Chon H, Shahzad M, Secord A. PHASE 2 TRIAL OF WEEKLY PACLITAXEL WITH PEMBROLIZUMAB IN PLATINUM RESISTANT RECURRENT OVARIAN CANCER. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2018. p. 20–20.
Published In
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
EISSN
1525-1438
ISSN
1048-891X
Publication Date
September 2018
Volume
28
Start / End Page
20 / 20
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences